FDA Cleared Of Wrongdoing In Generic Xibrom Suit
A Washington federal judge said Monday that the U.S. Food and Drug Administration had not improperly approved a generic version of Ista Pharmaceuticals Inc.'s post-cataract surgery eye drop medication, Xibrom....To view the full article, register now.
Already a subscriber? Click here to view full article